Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Anopheles gambiae Moesin/ezrin/radixin homolog 1 (Moe), partial CSB-YP766383BZL
CSB-EP766383BZL
CSB-BP766383BZL
CSB-MP766383BZL
CSB-EP766383BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Coatomer subunit gamma (gammaCop), partial CSB-YP766384BZL
CSB-EP766384BZL
CSB-BP766384BZL
CSB-MP766384BZL
CSB-EP766384BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Protein hook (hk), partial CSB-YP766385BZL
CSB-EP766385BZL
CSB-BP766385BZL
CSB-MP766385BZL
CSB-EP766385BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Adenylyltransferase and sulfurtransferase MOCS3 (AGAP001737) CSB-YP766386BZL
CSB-EP766386BZL
CSB-BP766386BZL
CSB-MP766386BZL
CSB-EP766386BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Probable dynactin subunit 2 (Dmn) CSB-YP766387BZL
CSB-EP766387BZL
CSB-BP766387BZL
CSB-MP766387BZL
CSB-EP766387BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Protein king tubby (king-tubby) CSB-YP766388BZL
CSB-EP766388BZL
CSB-BP766388BZL
CSB-MP766388BZL
CSB-EP766388BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Putative oxidoreductase GLYR1 homolog (AGAP009949), partial CSB-YP766389BZL
CSB-EP766389BZL
CSB-BP766389BZL
CSB-MP766389BZL
CSB-EP766389BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Probable protein-cysteine N-palmitoyltransferase porcupine (por), partial CSB-YP766390BZL
CSB-EP766390BZL
CSB-BP766390BZL
CSB-MP766390BZL
CSB-EP766390BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Kynurenine 3-monooxygenase (kh), partial CSB-YP766391BZL1
CSB-EP766391BZL1
CSB-BP766391BZL1
CSB-MP766391BZL1
CSB-EP766391BZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Mediator of RNA polymerase II transcription subunit 20 (MED20) CSB-YP766392BZL
CSB-EP766392BZL
CSB-BP766392BZL
CSB-MP766392BZL
CSB-EP766392BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (AGAP005199) CSB-YP766393BZL
CSB-EP766393BZL
CSB-BP766393BZL
CSB-MP766393BZL
CSB-EP766393BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae 40S ribosomal protein S14b (RpS14b) CSB-YP766394BZL
CSB-EP766394BZL
CSB-BP766394BZL
CSB-MP766394BZL
CSB-EP766394BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Gustatory and odorant receptor 7 (GPRor7), partial CSB-YP766395BZL1
CSB-EP766395BZL1
CSB-BP766395BZL1
CSB-MP766395BZL1
CSB-EP766395BZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Twinfilin (twf) CSB-YP766396BZL
CSB-EP766396BZL
CSB-BP766396BZL
CSB-MP766396BZL
CSB-EP766396BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Mediator of RNA polymerase II transcription subunit 18 (MED18) CSB-YP766397BZL
CSB-EP766397BZL
CSB-BP766397BZL
CSB-MP766397BZL
CSB-EP766397BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Eukaryotic translation initiation factor 3 subunit E (eIF3-S6) CSB-YP766398BZL
CSB-EP766398BZL
CSB-BP766398BZL
CSB-MP766398BZL
CSB-EP766398BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Adenylate kinase 2, mitochondrial (Adk2) CSB-YP766399BZL
CSB-EP766399BZL
CSB-BP766399BZL
CSB-MP766399BZL
CSB-EP766399BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lipoyl synthase, apicoplast (lipA) CSB-YP766400PMT
CSB-EP766400PMT
CSB-BP766400PMT
CSB-MP766400PMT
CSB-EP766400PMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cell division control protein 2 homolog (CRK2) CSB-YP766401PMT
CSB-EP766401PMT
CSB-BP766401PMT
CSB-MP766401PMT
CSB-EP766401PMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant T-cell immunomodulatory protein homolog (PY00695), partial CSB-YP766402PMT
CSB-EP766402PMT
CSB-BP766402PMT
CSB-MP766402PMT
CSB-EP766402PMT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>